Intrinsic Dissolution Test

Surface-area normalization is central because the measured dissolution slope depends on how much solid is exposed. Expressing the rate per unit area reduces the influence of compact size and particle-size differences, allowing researchers to compare drug substances more directly. This makes the result useful for distinguishing material-related dissolution behavior during pharmaceutical characterization and formulation development.

Crystal form, salt form, and ionization can produce different intrinsic dissolution rates. Crystal form changes the solid state being exposed, while salt form and ionization affect how the drug interacts with the dissolution medium. Testing at a specified pH helps reveal these differences, supporting selection and comparison of drug substances before clinical formulation decisions.

pH, temperature, and stirring rate are not incidental settings; they define the environment in which the solid surface dissolves. Holding them constant improves comparability among samples, while changing pH can expose ionization-related differences. Using controlled conditions also helps relate laboratory observations to dissolution behavior expected under differing gastrointestinal conditions.

The procedure begins by compacting powder into a disk so that a defined surface remains exposed. The disk is rotated in the selected medium, and solution samples are collected at successive time points. Plotting dissolved amount against time and normalizing the slope to exposed area yields the intrinsic dissolution rate for comparison.

Researchers apply these data during formulation development to identify drug substances whose dissolution behavior may affect product performance. The measurements also contribute to bioavailability assessment and drug classification because they characterize the substance itself without emphasizing particle-size effects. In clinical pharmaceutics, this links solid-state properties with decisions about how a formulation should be evaluated.

Comparing intrinsic dissolution rates across crystal or salt forms can show whether a change in solid-state or chemical form alters dissolution under the same conditions. Repeating the comparison at relevant pH values separates form-related effects from ionization-related effects. The resulting pattern helps predict how dissolution may change across gastrointestinal environments and guides further pharmaceutical characterization.